Takeover

Acquirers

Amgen Inc.

Targets
2
Filings
4
Median premium
116%
First filing
Aug 31, 2022
Latest filing
Jan 23, 2023

Targets

CompanyScore before dealScore nowFilingsLatest
Horizon Therapeutics Public Ltd Co0 / 7—2Jan 23, 2023
ChemoCentryx, Inc.——2Sep 14, 2022

Deal filings

FiledCompanyFormPricePremium
Jan 23, 2023Horizon Therapeutics Public Ltd CoDEFM14A$116.5044.44%
Dec 30, 2022Horizon Therapeutics Public Ltd CoPREM14A$116.5030.9%
Sep 14, 2022ChemoCentryx, Inc.DEFM14A$52.00116%
Aug 31, 2022ChemoCentryx, Inc.PREM14A$52.00116%